1st Quarter - Report

FINSTON CONSULTING, LLC for AMERICAN BIOINDUSTRY ALLIANCE (ALSO KNOWN AS ABSA)

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

To encourage the Congress and Executive Branch to oppose any attempts by foreign governments to negotiate new international agreements or to amend existing intellectual property agreements in the WTO and WIPO to weaken patent protection for biotechnology inventions. To encourage the Congress and the Executive Branch to oppose the inclusion of new, additional genetic resource source disclosure requirements for the patenting of biotechnology inventions in any ABS regime negotiated in the CBD.

LobbyistCovered position, as disclosed
SUSAN KLING FINSTON —

Contacted: U.S. Trade Representative (USTR); Smithsonian Institution; Patent & Trademark Office (PTO); State, Dept of (DOS); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Library of Congress (LOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.